National News
Will the Glaucoma Vision Act of 2026 Change Your Health Insurance Coverage?
Content Files PDF XML TEXT Metadata download Descriptive Metadata (MODS) Preservation Metadata (PREMIS) All Content and Metadata files, including granules ZIP
Last updated:
Key points
- Representative Frederica S. Wilson introduced H.R. 10476, the Glaucoma Vision Act of 2026, to mandate annual screenings for high-risk individuals.
- The legislation requires both public and private health insurance plans to cover these annual screenings.
- The bill authorizes $10 million over two fiscal years to fund CDC public health surveillance and National Eye Institute research.
NewsWK — A new federal legislative proposal could soon mandate health insurance plans to cover annual eye exams. Representative Frederica S. Wilson introduced the federal bill on September 16, 2026.
Why it matters
Therefore, this legislation impacts millions of Americans by placing new requirements on both public and private health insurance providers. Additionally, it authorizes millions in federal spending. This spending comes during a time of intense national debate over government expenditures.
What is the HR 10476 glaucoma screening insurance coverage bill?
The HR 10476 glaucoma screening insurance coverage bill mandates coverage for high-risk individuals. As a result, this mandate applies to both public and private health insurance plans. Furthermore, the bill directs federal funding toward public health surveillance to combat this leading cause of blindness.
The Frederica Wilson glaucoma bill, officially named the Glaucoma Vision Act of 2026, aims to improve early detection. Specifically, the legislation outlines several key initiatives:
- Mandatory annual screenings for high-risk patients.
- A $10 million federal investment for fiscal years 2027 and 2028.
- Support for the CDC‘s Vision Health Initiative.
How does the Glaucoma Vision Act of 2026 allocate research funding?
The bill authorizes $10 million over two fiscal years to fund community-based screening programs and CDC surveillance. Additionally, the legislation provides targeted federal funding for glaucoma research. Consequently, the National Eye Institute will administer these funds to develop new therapies.
House leaders referred the bill to the Committee on Energy and Commerce. Meanwhile, several national medical groups endorse the measure. These supporters include the American Academy of Ophthalmology, Prevent Blindness, and the American Glaucoma Society. Ultimately, these groups argue that early testing prevents long-term vision loss.
This article was produced with the assistance of AI and reviewed by our editorial team.
Sources
Related: Study Examines Women on Parole Mental Health and Reentry Crises Across the US
Related: House Resolution 1499 Clears Way for Critical Votes on Mining, Higher Education, and Maritime Rules
See a typo? Report it here.
